<DOC>
	<DOCNO>NCT01533597</DOCNO>
	<brief_summary>The aim study investigate combination therapy consist anticholinergic plus alpha-blocker could beneficial woman suffer Overactive Bladder ( OAB ) .</brief_summary>
	<brief_title>The Efficacy Solifenacin With Without Tamsulosin Adult Women With Overactive Bladder ( OAB )</brief_title>
	<detailed_description>Overactive bladder ( OAB ) describe symptom complex urgency , without urge incontinence , usually frequency nocturia . The low urinary tract innervate parasympathetic sympathetic nervous system , act via muscarinic adrenergic receptor , respectively . Antimuscarinics mainly use treatment patient OAB , especially woman . Other antimuscarinics , a1-blockers show several clinical report useful treat DO cause neurological disease .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Female age 20 ≤ ＜ 70 year History OAB symptom ≥ 3 month International Prostate Symptom Score ( IPSS ) ≥ 8 point Screening 3 total score 2 Q 3 index OABSS questionnaire An average ≥ 8 micturition per 24 hour ≥ 1 urgency ( define level 3 5 5 point Urinary Sensation Scale ) episode ( without incontinence ) per 24 hour document 3day micturition diary Uroflowmetry Q max ≤ 10 mL/sec , Post Void Residual Volume ≥ 15 % voided urine Any condition would contraindicate usage anticholinergic alpha blocker History low urinary tract surgery ( e.g . incontinence surgery electrostimulation ) History stress urinary incontinence urinary retention History interstitial cystitis , bladder outlet obstruction significant genitourinary disorder Pregnant nursing woman Current urinary tract infection Neurological bladder dysfunction Treatment drug may interfere CYP3A4 metabolic function Significant hepatic renal disease Any condition , opinion investigator , make patient unsuitable inclusion</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Overactive bladder</keyword>
	<keyword>Solifenacin succinate</keyword>
	<keyword>Tamsulosin</keyword>
</DOC>